Page last updated: 2024-10-29

indirubin-3'-monoxime and Pancreatic Neoplasms

indirubin-3'-monoxime has been researched along with Pancreatic Neoplasms in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sano, M1
Ichimaru, Y1
Kurita, M1
Hayashi, E1
Homma, T1
Saito, H1
Masuda, S1
Nemoto, N1
Hemmi, A1
Suzuki, T1
Miyairi, S1
Hao, H1

Other Studies

1 other study available for indirubin-3'-monoxime and Pancreatic Neoplasms

ArticleYear
Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
    Cancer letters, 2017, 07-01, Volume: 397

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell L

2017